New Delhi: Bharat Biotech on Saturday said Prime Minister Narendra Modi's visit to the company's manufacturing facility in Genome Valley in Hyderabad further reinforces its commitment towards scientific discovery and solving public health issues.
Modi visited Bharat Biotech's facility located at Genome Valley and reviewed the progress of Covaxin, a vaccine candidate for COVID-19 being developed by the company.
"The prime minister's visit serves as a great inspiration to our team, and further reinforces our commitment towards scientific discovery, solving public health issues, and the nation's fight against COVID-19," Bharat Biotech said in a statement.
